Acres Commercial Realty Corp
Real Estate
Acres Commercial Realty Corp (ACR) Stock News
The latest ACR headlines and market coverage — 3 recent stories, updated throughout the day.
- GlobeNewswire Inc.·Neutral
Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy
A phase III randomized trial published in the New England Journal of Medicine found that two years of lenalidomide maintenance therapy provides equivalent overall survival to indefinite treatment for standard-risk multiple myeloma patients. The study of 516 patients showed 68.6% vs 69.0% survival rates at seven years, with indefinite treatment associated with higher toxicity and second primary cancer incidence. Results suggest fixed-duration maintenance could become the new standard of care.
- GlobeNewswire Inc.·
LACROIX : Bilan semestriel du contrat de liquidité.
LACROIX Group released its H1 2026 liquidity contract report showing 5,256 shares and €73,233.86 in cash as of June 30, 2026. The company reported Q1 2026 revenue of €122.8 million, up 5.9% year-over-year, with stabilization in Electronics activity and strong growth in the Environment segment. The group is implementing a €77 million investment program.
- Benzinga·
ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock
ACRES Commercial Realty Corp. announced quarterly cash dividends on its preferred stock. The Series C Preferred Stock will pay $0.5993994 per share on July 30, 2026, while the Series D Preferred Stock will pay $0.4921875 per share on the same date. Both dividends reflect the company's commitment to returning capital to preferred shareholders.